Publication Date
| In 2025 | 0 |
| Since 2024 | 1 |
| Since 2021 (last 5 years) | 1 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Attention Deficit… | 2 |
| Patients | 2 |
| Adults | 1 |
| Drug Therapy | 1 |
| Evaluation Methods | 1 |
| Foreign Countries | 1 |
| Medicine | 1 |
| Merchandise Information | 1 |
| Outcomes of Treatment | 1 |
| Pediatrics | 1 |
| Quality of Life | 1 |
| More ▼ | |
Author
| Asam Latif | 1 |
| Cates, Charlotte | 1 |
| Laila Tanana | 1 |
| Matza, Louis S. | 1 |
| Murray, Lindsey T. | 1 |
| Prasad S. Nishtala | 1 |
| Timothy F. Chen | 1 |
| Van Brunt, David L. | 1 |
Publication Type
| Journal Articles | 2 |
| Information Analyses | 1 |
| Reports - Evaluative | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
| United States | 2 |
| Australia | 1 |
| Canada | 1 |
| New Zealand | 1 |
| United Kingdom | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkLaila Tanana; Asam Latif; Prasad S. Nishtala; Timothy F. Chen – Journal of Attention Disorders, 2024
Objective: This study aimed to compare the approval of medicines for attention deficit/hyperactivity disorder (ADHD) for pediatric patients across five countries. Method: A document analysis was completed, using the drug labeling for ADHD medicines from five countries; United Kingdom, Australia, New Zealand, Canada and United States (US).…
Descriptors: Medicine, Drug Therapy, Attention Deficit Hyperactivity Disorder, Merchandise Information
Matza, Louis S.; Van Brunt, David L.; Cates, Charlotte; Murray, Lindsey T. – Journal of Attention Disorders, 2011
Aims: Childhood attention-deficit/hyperactivity disorder (ADHD) frequently persists into adulthood and continues to impair health-related quality of life (HRQL). Thus, it is important to have validated symptom and HRQL measures for assessing treatment outcomes in this population. The purpose of the current analysis was to assess test-retest…
Descriptors: Attention Deficit Hyperactivity Disorder, Quality of Life, Test Reliability, Patients
